Work

Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma

Year: 2024

Type: article

Abstract: Glioblastoma (GBM) remains a formidable challenge in neuro-oncology due to its aggressive nature and propensity for therapeutic resistance. Anti-vascular endothelial growth factor (VEGF) therapies, although promising, often encounter resistance that limits their clinical efficacy. A multi-target and multi-drug approach has emerged as compelling strategies to address this resistance to enhance the treatment outcomes. This review examines the complex environment of anti-VEGF resistant GBM and analyses a multi-target therapeutic approach using natural products.

Source: Exploration of Drug Science

DOI: 10.37349/eds.2024.00062